AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
GeneDx Holdings Corp. Faces Securities Lawsuit Over Alleged Misleading Business Information.
ByAinvest
Sunday, Aug 31, 2025 9:39 am ET1min read
Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. (NASDAQ: WGS) regarding allegedly misleading business information. Investors who purchased GeneDx securities may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, visit https://rosenlegal.com/submit-form/?case_id=40333 or call 866-767-3653.
New York, NY - Rosen Law Firm, a globally recognized investor rights law firm, has initiated an investigation into potential securities claims against GeneDx Holdings Corp. (NASDAQ: WGS). The firm is exploring allegations that the company may have issued materially misleading business information to the investing public, potentially entitling investors to compensation.On February 5, 2025, Grizzly Research published a report titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report stated that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. This revelation led to a significant drop in GeneDx's stock price, falling 6.7% on the same day [1].
Rosen Law Firm is preparing a class action seeking recovery of investor losses. Investors who purchased GeneDx securities may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, investors can visit [Rosen Legal](https://rosenlegal.com/submit-form/?case_id=40333) or contact Phillip Kim, Esq. toll-free at 866-767-3653 or via email at case@rosenlegal.com [2].
The Rosen Law Firm is known for its expertise in securities class actions and shareholder derivative litigation, having recovered hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors [3]. Investors are advised to select qualified counsel with a proven track record of success.
References:
[1] https://www.marketscreener.com/news/rosen-nationally-regarded-investor-counsel-encourages-genedx-holdings-corp-investors-to-inquire-a-ce7c50d2d98bff2d
[2] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302542137.html
[3] https://www.ainvest.com/news/genedx-holdings-corp-investigation-potential-securities-claims-2508/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet